Investigators found chance of death increased by about 30% for those living in areas of poverty.
MHI had the strongest association with both overall survival and, specifically, survival from anal cancer. Other secondary predictors of lower survival from anal cancer include gender (men are more vulnerable), older age, African-American race, unmarried status, and, time of diagnosis.
The data included a total of 9,550 study participants. MHI, age, sex, race, marital status, stage and grade of cancer, year of diagnosis, and radiation-treatment status were recorded.
NYU Langone Medical Center is an academic medical center affiliated with New York University. The center is dedicated to patient care, education, and research.
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support
Abbott announces quarterly common dividend
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli